FRANKFURT, Jamus–(WIRE KASUWANCI)–Merz Therapeutics, jagora a fannin neurotoxins da kasuwanci a ƙarƙashin ƙungiyar Merz, da Teijin Pharma Limited, babban kamfani na kasuwancin kiwon lafiya na Teijin Group, tare da sanar a yau cewa Teijin Pharmaceuticals ya ci nasara. yarda daga Ma'aikatar Lafiya, Ma'aikata da Jin Dadin Jama'a (MHLW) don amfani da Xeomin® (incobotulinumtoxinA) a cikin raka'a 50, 100 ko 200 na allurar intramuscularly don maganin spasms na ƙananan ƙafa.
Ƙarƙashin ƙafar ƙafa alama ce ta ciwo na neuron na sama, wanda aka fi bayyana ta hanyar ƙara yawan sautin tsoka na gaɓoɓin gabobi da kuma wuce gona da iri na miƙewa a matsayin ci gaba na bugun jini.Babban alamun alamun suna da wahala wajen tafiya akai-akai da kuma ƙara haɗarin faɗuwa saboda gangar jikin da ba ta da ƙarfi, rikitarwa ko abubuwan da suka toshe a rayuwar yau da kullun.Magani na al'ada don ɓarna ƙafa ya haɗa da gyaran jiki da kuma amfani da masu shakatawa na tsoka na baki ko masu hana neuromuscular, irin su botulinum toxin type A.
Stefan Brinkmann, Shugaba na Merz Therapeutics, ya ce: "Tsarin amincewa yana nuna muhimmin ci gaba ga Merz Therapeutics kuma sakamakon haɗin gwiwarmu da Teijin Pharmaceuticals.Muna fatan abokan aikinmu za su sami nasarar gabatar da wannan muhimmin alamar cutarwa ga likitocin Japan da marasa lafiya. "
Dokta Stefan Albrecht, Babban Mataimakin Shugaban Global R & D, Merz Therapeutics: "Wannan lakabin fadadawa a Japan wani babban misali ne na fa'idodin da Xeomin ® ke bayarwa ga yawancin marasa lafiya tare da spasticity post-stroke.Likitoci yanzu za su iya zaɓar yin maganin spasticity na ƙasa da na sama, ko kuma za su iya zama masu sassauƙa kamar yadda ake buƙata Aiwatar da allurai guda ɗaya a hankali.Muna alfahari da wannan nasarar, musamman kyakkyawar hadin gwiwa tare da abokin aikinmu Teijin."
Shugaban Teijin Pharmaceutical Ichiro Watanabe ya ce: “Teijin Pharmaceutical yana ba da magunguna iri-iri, gami da maganin kasusuwa da na’urorin kiwon lafiya, kamar sautin sautin da ke hanzarta warkar da karaya ga majinyata masu fama da cututtukan musculoskeletal.Dangane da sauye-sauyen alƙaluma da haɓaka wayar da kan jama'a, Muna ƙaddamar da sabbin magunguna da mafita masu inganci, gami da fahimtar al'umma mai dorewa.Teijin Pharmaceuticals ya ci gaba da ba da gudummawa don inganta ingancin rayuwa (QOL) na marasa lafiya ta hanyar samar da sabbin hanyoyin magance cututtukan da ba su cika buƙatun ba.”
Xeomin® yana magance ƙarshen jijiya cholinergic yadda ya kamata ta hanyar raunana ƙanƙantar tsokoki na son rai, kuma yana kawar da tashin hankali na tsoka ta hanyar hana sakin na'ura mai kwakwalwa da ake kira acetylcholine.Neurotoxin da aka tsarkake sosai shine kawai sashi mai aiki a cikin Xeomin®.Ana yin ta ne ta hanyar cire hadaddun sunadarai daga nau'in gubar botulinum A da Clostridium botulinum ke samarwa ta hanyar amfani da fasahar tsarkakewa da Merz Pharma GmbH & Co. KGaA suka kirkira.Rashin hadaddun sunadaran suna ba da damar Xeomin® don rage samar da ƙwayoyin rigakafi waɗanda zasu iya rage inganci.An sami gagarumin ci gaba a makin flexor wanda aka gyara ashworth sikelin (MAS) a cikin gwajin asibiti na kashi III a Japan.
Ana rarraba Xeomin® ta Merz Pharmaceuticals GmbH a cikin ƙasashe sama da 70 kuma ana amfani dashi don kula da marasa lafiya da spasm na sama, dystonia na mahaifa, blepharospasm ko salivation mai yawa.Teijin Pharmaceuticals sun sanya hannu kan keɓaɓɓen lasisi da yarjejeniyar haɓaka haɗin gwiwa don Xeomin® a Japan tare da Merz a cikin 2017, kuma sun fara siyar da Xeomin® na keɓance a cikin Disamba 2020 bayan samun izini daga Ma'aikatar Lafiya, Ma'aikata da walwala (MHLW) na Japan.Dangane da gwajin asibiti na Merz's Phase III a Japan, sabbin ƙarin yarda da aka samu sun canza wasu abubuwan da aka yarda da su.
Gabaɗaya, ga manya, ya kamata a yi allurar Xeomin® a cikin tsayayyen tsokoki da yawa.* Matsakaicin adadin kowace gwamnati shine raka'a 400, amma yakamata a rage shi da kyau zuwa mafi ƙarancin kashi gwargwadon nau'in da adadin tsokar tonic.Idan tasirin maganin da ya gabata ya ragu, ana ba da izinin maimaita allurai.Tsawon maganin ya kamata ya zama makonni 12 ko ya fi tsayi, amma ana iya rage shi zuwa makonni 10 dangane da alamun cutar.
* Myotonic: gastrocnemius (madadin kai, kai na gefe), tafin hannu, tibialis na baya, flexor digitorum longus, da sauransu.
Merz Therapeutics kasuwanci ne na Merz Pharmaceuticals GmbH wanda aka sadaukar don inganta rayuwar marasa lafiya a duniya.Tare da bincike marar iyaka, haɓakawa da al'adun ƙirƙira, Merz Therapeutics yana ƙoƙari don saduwa da buƙatun marasa lafiya da samun sakamako mafi kyau.Merz Therapeutics yana neman biyan buƙatun musamman na mutanen da ke fama da rikice-rikice na motsi, cututtukan jijiyoyin jiki, cututtukan hanta, da sauran yanayin kiwon lafiya waɗanda ke tasiri sosai ga ingancin rayuwar marasa lafiya.Merz Therapeutics yana da hedikwata a Frankfurt, Jamus, tare da ofisoshin wakilai a cikin ƙasashe sama da 90, da kuma reshen Arewacin Amurka a Raleigh, North Carolina.Merz Pharmaceuticals GmbH wani bangare ne na Merz Group, kamfani mai zaman kansa na iyali wanda ya himmatu wajen haɓaka sabbin abubuwa waɗanda ke biyan bukatun marasa lafiya da abokan ciniki sama da shekaru 110.
Teijin (Tokyo Stock Exchange code: 3401) ƙungiya ce ta fasaha ta duniya wacce ke ba da mafita na ci gaba a fagen darajar muhalli;aminci, tsaro, da rage bala'i;da kuma sauye-sauyen al'umma da kuma kara wayar da kan jama'a game da kiwon lafiya.An kafa Teijin a cikin 1918 a matsayin farkon masana'anta na rayon a Japan, kuma yanzu ya haɓaka zuwa kamfani na musamman wanda ke rufe mahimman wuraren kasuwanci guda uku: kayan aiki masu inganci waɗanda suka haɗa da aramid, fiber carbon da kayan haɗin gwiwa, da kuma sarrafa guduro da filastik, Fim. , fiber polyester da sarrafa samfur;kulawar likita, ciki har da magunguna da kayan aikin kiwon lafiya na gida don kashi / haɗin gwiwa, tsarin numfashi, da cututtukan zuciya / cututtukan zuciya, kulawa da kulawa da pre-symptomatic;da IT, gami da hanyoyin likitanci, kamfanoni da B2B don tsarin jama'a, da kuma kayan aikin software da sabis na kan layi na B2C don nishaɗin dijital.Kamar yadda aka bayyana a cikin sanarwar alama "Human Chemistry, Human Solutions", Teijin ya himmatu sosai ga masu ruwa da tsaki kuma yana da niyyar zama kamfani wanda ke tallafawa al'umma ta gaba.Ƙungiyar ta ƙunshi fiye da kamfanoni 170 kuma tana da kusan ma'aikata 20,000 a kasashe / yankuna 20 na duniya.A cikin kasafin kudin shekarar da ya ƙare 31 ga Maris, 2021, Teijin ya ba da sanarwar haɓaka tallace-tallace na yen biliyan 836.5 (dala biliyan 7.7) da jimlar kadarori na yen biliyan 1.036.4 (dala biliyan 9.5).
Lokacin aikawa: Satumba-10-2021